InvestorsHub Logo
Followers 18
Posts 1093
Boards Moderated 0
Alias Born 05/12/2007

Re: urche post# 114

Friday, 09/16/2011 1:34:41 PM

Friday, September 16, 2011 1:34:41 PM

Post# of 233
No problem.

I agree that both companies are becoming more and more disingenuous and I think it is hurting the stock valuation of each. I have read through all of the court documents. While I am not enough of a legal expert to opine on the end result, it seems readily apparent that both ALNY and TKMR have violated their contracts at some point(s) in time. I don't see anything to convince me that TKMR would win the case, but ALNY may well cut a deal. My favorite part of the hundreds of pages of legalese and contracts is the one paragraph letter in which the ALNY CEO got the TKMR CEO to sign off that MC3 is a "lipid to which Alnylam has exclusive rights"

I do own ALNY (recently doubled my small position at ~6.50), and am considering adding some TKMR too

Any comments here may have previously been disseminated on Twitter @BioDueDiligence or at www.biotechduediligence.com

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ALNY News